Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.
about
Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients--a pharmacoeconomic analysis.Venous thromboembolism in medical inpatients--the silent epidemic of neglect
P2860
Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cost-effectiveness analysis of ...... in internal medicine patients.
@ast
Cost-effectiveness analysis of ...... in internal medicine patients.
@en
type
label
Cost-effectiveness analysis of ...... in internal medicine patients.
@ast
Cost-effectiveness analysis of ...... in internal medicine patients.
@en
prefLabel
Cost-effectiveness analysis of ...... in internal medicine patients.
@ast
Cost-effectiveness analysis of ...... in internal medicine patients.
@en
P1433
P1476
Cost-effectiveness analysis of ...... in internal medicine patients.
@en
P2093
P356
10.1016/S0049-3848(98)00206-0
P577
1999-04-01T00:00:00Z